phase readout
saveNCT05676697: PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy
TERMINATEDupdated 5d ago
community read0 votes
Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE1. Conditions: Autoimmune Hemolytic Anemia, Failure of Two Rounds of Treatment
view source ↗
comments(0)
5-min edit window · permanent after that